Open innovation in drug development
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca shares insights on how greater transparency…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Juilee Dandekar
Why COVID-19 presents a golden opportunity to Indian pharma firms
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc's…
Race to find a viable vaccine: Can Indian firms rise to the challenge?
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to…
COVID–19 and its impact on India Pharma Inc
Juilee Dandekar – Sector Expert (Healthcare), Business Research & Advisory, Aranca, among other things, believes that India…